FAT1 and non-small cell lung carcinoma: Fat1 activates the Hippo signalling pathway by promoting nuclear translocation of YAP1, which reduces the sphere‐forming ability and expression of tumour initiation markers in NSCLC cells, suggesting that Fat1 can inhibit NSCLC tumour initiation.27